HC Wainwright & Co. Initiates Coverage On Vigil Neuroscience with Buy Rating, Announces Price Target of $24
HC Wainwright & Co. analyst Andrew Fein initiates coverage on Vigil Neuroscience (NASDAQ:VIGL) with a Buy rating and announces Price Target of $24.